eblast

Hereditary Cancer: Harness Genomic Insights

The National Cancer Institute estimates that 5–10% of cancers are inherited cancers.

Identifying gene variants associated with increased risk can aid early intervention strategies to better manage patient risk of developing hereditary cancer as well as guide targeted therapy decisions for those with a diagnosis.

ARUP Laboratories offers hereditary cancer testing for many types of cancer and conditions, including:

• Breast, ovarian, and endometrial cancers
• Gastrointestinal cancers
• Endocrine cancers, including pancreatic cancer and thyroid cancer
• Prostate cancer
• And more

Let’s manage cancer risk together.

Why Choose ARUP?

With every point of genomic data we sequence, we build a snapshot of your patient’s health status. With each snapshot, we help you personalize treatment for your patient.

Personalized Service That Transcends Data

• A member from our team of pathologists, genetic counselors, and clinical variant scientists personally reviews each case to ensure accuracy and relevancy. By integrating their knowledge of the latest guidance for gene interpretation with each patient’s clinical context, our experts personalize diagnostic medicine.
• We provide customized reporting with patient-specific details to offer individualized and actionable insights.
• Select the test combination that best suits your patient’s needs. We offer both multigene panels and single gene tests that include:
  • Overlapping genes relevant to most cancer syndromes
  • Genes unique to specific familial cancer types

Learn more

Receive the Latest Updates Subscribe to the ARUP Consult monthly newsletter to be notified about updated topics and testing recommendations.
Subscribe